Oculis Holding AG Ordinary shares (OCS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $425.11M
Last updated: Nov 17, 2026 at 4:10 PM ET
Oculis Holding AG Ordinary shares (OCS) Stock Chart
Oculis Holding AG Ordinary shares (OCS) has a latest price of $7.51 on Nov 17, 2026, 78.2% below its 52-week high of $34.48. Its price fell 61.7% over the past 12 months. The month-end price fell 15.7% over the 3 years through Oct 2026, a compound annual decline of 5.5%.
Price Chart
From Mar 2023 to Oct 2026, its highest month-end close was $29.41 in Feb 2026 and its lowest $7.43 in Mar 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart OCS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OCS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 44.7%, and over 6 months it fell 73.1%.
| Period | Change |
|---|---|
| 1 month | +2.6% |
| 3 months | -44.7% |
| 6 months | -73.1% |
| 12 months | -61.7% |
| 12 months, with dividends | -61.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -15.7% | -5.5% |
Price by Year
Its best calendar year was 2024, when the price rose 51.4%, and its weakest was 2025, when it rose 17.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $8.26 | -58.6% |
| 2025 | $19.97 | +17.5% |
| 2024 | $17.00 | +51.4% |
Trading Range
The price is 12.2% below its 50-day average of $8.56 and 57.5% below its 200-day average of $17.65.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $7.51 | |
| 52-week high | $34.48 | -78.2% |
| 52-week low | $6.78 | +10.8% |
| 50-day average | $8.56 | -12.2% |
| 200-day average | $17.65 | -57.5% |
Price Risk
Over 3 years, its largest fall from a peak was 79.1%.
| Measure | Value |
|---|---|
| 1-year beta | 1.06 |
| Largest fall, 1 year | -79.1% |
| Largest fall, 3 years | -79.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About OCS
What is OCS's 1-year price change?
Oculis Holding AG Ordinary shares's price fell 61.7% over the past 12 months. With dividends included, the 12-month total return was -61.7%.
How has OCS stock done over the long term?
Oculis Holding AG Ordinary shares's month-end price fell 15.7% over the 3 years through Oct 2026, a compound annual decline of 5.5%. These figures leave out dividends.
What is OCS's 52-week high and low?
Oculis Holding AG Ordinary shares's 52-week high is $34.48 and its 52-week low is $6.78. Its latest price of $7.51 on Nov 17, 2026 is 78.2% below the high.
What is OCS's beta?
Oculis Holding AG Ordinary shares's 1-year beta against the S&P 500 is 1.06, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 79.1%.
Is the OCS chart free?
Yes. Advanced Charting for OCS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
OCS pages: Overview, Charting, Financials, Statistics, Competitors